Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Road To Biosimilar Interchangeability Could Be Through Market Experience

Executive Summary

Demonstrating that a biosimilar is interchangeable with its reference product may be a subject for post-market studies rather than clinical trials, according to Kathleen Sanzo, partner at Morgan, Lewis and Bockius

You may also be interested in...



Biosimilars May Drift, But What Should FDA Do About It?

Another balance FDA likely will have to strike in its emerging biosimilars pathway is letting innovators improve and update manufacturing processes while ensuring similar biologics can remain similar to their reference products.

Biosimilars May Drift, But What Should FDA Do About It?

Another balance FDA likely will have to strike in its emerging biosimilars pathway is letting innovators improve and update manufacturing processes while ensuring similar biologics can remain similar to their reference products.

FDA Creates Biosimilars Overseer In Drug Office; Internal Panel To Advise Application Reviewers

Leah Christl brings molecular and cellular biology background to the job of implementing an approval pathway for biosimilars.

Related Content

Topics

UsernamePublicRestriction

Register

PS052286

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel